Late versus non-late presentation of HIV/AIDS: an economic impact analysis

por Grabmeier-Pfistershammer, K, Rieger, A, Schroeck, T, Schlag, M
Publicado 2010

Clinical Challenges in the Management of Leishmania/HIV Coinfection in a Nonendemic Area: A Case Report

por Grabmeier-Pfistershammer, K., Poeppl, W., Brunner, P. M., Rappersberger, K., Rieger, A.
Publicado 2012

Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients

por Lagler, H, Grabmeier-Pfistershammer, K, Touzeau-Römer, V, Tobudic, S, Rieger, A, Burgmann, H
Publicado 2010

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

por Thoden, J., Potthoff, A., Bogner, J. R., Brockmeyer, N. H., Esser, S., Grabmeier-Pfistershammer, K., Haas, B., Hahn, K., Härter, G., Hartmann, M., Herzmann, C., Hutterer, J., Jordan, A. R., Lange, C., Mauss, S., Meyer-Olson, D., Mosthaf, F., Oette, M., Reuter, S., Rieger, A., Rosenkranz, T., Ruhnke, M., Schaaf, B., Schwarze, S., Stellbrink, H. J., Stocker, H., Stoehr, A., Stoll, M., Träder, C., Vogel, M., Wagner, D., Wyen, C., Hoffmann, C.
Publicado 2013